AC Immune SA   Report issue

For profit Phase 2
Founded: Lausanne Switzerland (2003)

Organization Overview

First Clinical Trial
2016
NCT02738450
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

AC Immune SA